How has been the historical performance of Hemo Organic?

Answer:The historical performance of Hemo Organic shows a significant increase in net sales, reaching 2.41 Cr in March 2025, up from just 0.02 Cr in March 2024 and 0.00 Cr in March 2023. Total operating income also rose sharply to 2.41 Cr in March 2025, compared to 0.02 Cr in the previous year. However, the company faced total expenditures of 2.46 Cr in March 2025, leading to an operating profit (PBDIT) of only 0.02 Cr, a slight improvement from -0.25 Cr in March 2024. The profit before tax turned positive at 0.03 Cr in March 2025, while the profit after tax was reported at 0.16 Cr, a notable recovery from a loss of -0.26 Cr in March 2024. The earnings per share (EPS) also improved to 0.46 in March 2025, compared to -0.75 in the prior year.

Breakdown:
Hemo Organic's financial trajectory has shown a remarkable turnaround in recent years, particularly in March 2025, where net sales surged to 2.41 Cr from a mere 0.02 Cr in March 2024. This growth in revenue was accompanied by total operating income that mirrored the sales figures, indicating a strong operational performance. Despite the increase in income, total expenditures also rose to 2.46 Cr, which resulted in a modest operating profit of 0.02 Cr, improving from a significant loss the previous year. The company achieved a profit before tax of 0.03 Cr and a profit after tax of 0.16 Cr, marking a substantial recovery from losses in prior years. The earnings per share reflected this positive trend, climbing to 0.46, showcasing Hemo Organic's potential for future growth.